2 ptits nouveaux sur medscape

• 
  CME The Link Between
  NSAIDs, Blood Pressure, and Cardiovascular Events Condition:
  Hypertensionto it, so that when the patient
  takes the medication -- it's called naproxcinod -- the nitric
  oxide acts as a vasodilator and offsets some of the ...MedscapeCME Cardiology, April 2010
  
• 
  CME NSAIDs, Renal
  Function, and Hypertensionfor example, one to
  be available in the not-too-distant future is naproxcinod, which
  is a nitric oxide molecule linkage to naproxen such that when ...April 2010
  

The Links Among NSAIDs, Blood Pressure, and Cardiovascular Events in
Patients With Osteoarthritis CME



Michael Weber, MD; Christopher Chappel, MD; William
White, MD; Domenic A. Sica, MD



CME Released: 04/16/2010; Valid for credit
through 04/16/2011
Authors and Disclosures


Michael Weber, MD
Professor of Medicine, State University of New
York, Downstate College of Medicine, Brooklyn, New York
Disclosure:
Served as an advisor or consultant for: Boehringer Ingelheim
Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi Sankyo,
Inc., Forest Laboratories, Inc., Gilead Sciences Inc., GlaxoSmithKline,
Novartis Pharmaceuticals Corporation, Takeda Pharmaceuticals North
America, Inc.
Served as a speaker or a member of a speakers bureau for: Boehringer
Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi
Sankyo, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis
Pharmaceuticals Corporation, sanofi-aventis

Dr. Weber does not intend to discuss off-label uses of
drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.

Dr. Weber does not intend to discuss investigational
drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.
Christopher Chappel, MD
Medical Director, Chappel Family Practice,
Kissimmee, Florida
Disclosure: Served as a speaker or a member of a
speakers bureau for: Novartis Pharmaceuticals Corporation, Strativa
Pharmaceuticals

Dr. Chappel does not intend to discuss off-label uses
of drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.

Dr. Chappel does not intend to discuss investigational
drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.
William White, MD
Professor and Chief, Division of Hypertension
& Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center,
University of Connecticut School of Medicine, Farmington, Connecticut
Disclosure:
Served as an advisor or consultant for: NicOx

Dr. White does not intend to discuss off-label uses of
drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.

Dr. White does intend to discuss investigational drugs,
mechanical devices, biologics, or diagnostics not approved by
the FDA for use in the United States.
Domenic A. Sica, MD
Professor of Medicine, Medical College of
Virginia Campus, Commonwealth University, Richmond, Virginia
Disclosure:
Served as an advisor or consultant for: NicOx

Dr. Sica does not intend to discuss off-label uses of
drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.

Dr. Sica does not intend to discuss investigational
drugs, mechanical devices, biologics, or diagnostics not approved
by the FDA for use in the United States.
Sarah Williams, PhD
Scientific Director, Medscape/theheart.org
Disclosure:
Sarah Williams, PhD, has disclosed no relevant financial relationships.
Laurie E. Scudder, MS, NP
Accreditation Coordinator, Continuing
Professional Education Department, Medscape, LLC; Clinical Assistant
Professor, School of Nursing and Allied Health, George Washington
University, Washington, DC; Nurse Practitioner, School-Based Health
Centers, Baltimore City Public Schools, Baltimore, Maryland
Disclosure:
Laurie E. Scudder, MS, NP, has disclosed no relevant financial
relationships.
Learning Objectives


At the conclusion of this program, participants will be able
to:

1. Evaluate the cardiovascular risks and comorbidities in patients who
   have osteoarthritis
   
2. Analyze the challenges of using NSAIDs and COX-2 inhibitors
   to treat inflammation in patients who have cardiovascular risk factors
   
3. Demonstrate why increases in blood pressure can be dangerous in
   some patients with osteoarthritis
   

Credits Available


Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing continuing
education credit for this activity will be issued a certificate of
participation.

Physicians should only claim credit commensurate with the extent of
their participation in the activity.
Accreditation Statements


For Physicians




Medscape, LLC is accredited by the Accreditation
Council for Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.

Medscape, LLC designates this educational activity
for a maximum of 0.5
AMA PRA Category 1 Credit(s)
. Physicians should only claim credit
commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial
relationships.
Contact This Provider

For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact CME@medscape.net

CME
Released: 04/16/2010; Valid for credit through 04/16/2011



Instructions for Participation and Credit


There are no fees for participating in or receiving credit
for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please
consult your professional licensing board.

This activity is designed to be completed within the time designated on
the title page; physicians should claim only those credits that reflect
the time actually spent in the activity. To successfully earn credit,
participants must complete the activity online during the valid credit
period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

1. Read the target audience, learning objectives, and author
   disclosures.
   
2. Study the educational content online or printed out.
   
3. Online, choose the best answer to each test question. To receive
   a certificate, you must receive a passing score as designated at the
   top of the test. MedscapeCME encourages you to complete the Activity
   Evaluation to provide feedback for future programming.
   

You may now view or print the certificate from your CME/CE Tracker. You
may print the certificate but you cannot alter it. Credits will be
tallied in your CME/CE Tracker and archived for 6 years; at any point within
this time period you can print out the tally as well as the certificates
by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.


essai
http://74.125.77.132/search?q=cache:aDWByYzBOOwJ:cme.medscape.com/viewprogram/30763+%23+%23+CME+NSAIDs,+Renal+Function,+and+Hypertension&cd=1&hl=fr&ct=clnk&gl=fr&client=firefox-a

aussi sur ce lien

http://74.125.77.132/search?q=cache:GYP3BfVUHf0J:www.theheart.org/article/1061183.do+NSAIDs,+Blood+Pressure,+and+Cardiovascular+Events+Condition:+Hypertensiont&cd=2&hl=fr&ct=clnk&gl=fr

Encore et toujours Merci Vinsse !

çà va bien finir par "payer" !

Bonne journée
D@n

Thank you le picard !

merci beaucoup vinsse , encore des choses qu'on ne pourrait pas lire si tu n'étais pas là !